These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18378946)

  • 21. A higher ratio of refined grain to whole grain is associated with a greater likelihood of chronic kidney disease: a population-based study.
    Mazidi M; Katsiki N; Mikhailidis DP; Banach M
    Br J Nutr; 2019 Jun; 121(11):1294-1302. PubMed ID: 30375292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Hiramoto JS; Katz R; Peralta CA; Ix JH; Fried L; Cushman M; Siscovick D; Palmas W; Sarnak M; Shlipak MG
    Am J Kidney Dis; 2012 Aug; 60(2):225-32. PubMed ID: 22560844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Ix JH; Shlipak MG; Katz R; Budoff MJ; Shavelle DM; Probstfield JL; Takasu J; Detrano R; O'Brien KD
    Am J Kidney Dis; 2007 Sep; 50(3):412-20. PubMed ID: 17720520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension.
    Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Gotoh A; Uchida K; Higaki J
    Clin Exp Hypertens; 2006 Jul; 28(5):451-61. PubMed ID: 16820342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
    Garcia-Garcia P; Castejon R; Tutor-Ureta P; Silvestre RA; Mellor-Pita S; Jimenez-Ortiz C; Yebra-Bango M
    Clin Rheumatol; 2017 Dec; 36(12):2709-2717. PubMed ID: 28914371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological Variability of Estimated GFR and Albuminuria in CKD.
    Waikar SS; Rebholz CM; Zheng Z; Hurwitz S; Hsu CY; Feldman HI; Xie D; Liu KD; Mifflin TE; Eckfeldt JH; Kimmel PL; Vasan RS; Bonventre JV; Inker LA; Coresh J;
    Am J Kidney Dis; 2018 Oct; 72(4):538-546. PubMed ID: 30031564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA; Jacobs DR; Katz R; Ix JH; Madero M; Duprez DA; Sarnak MJ; Criqui MH; Kramer HJ; Palmas W; Herrington D; Shlipak MG
    Am J Kidney Dis; 2012 Jan; 59(1):41-9. PubMed ID: 22000727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cystatin C, creatinine-based estimated glomerular filtration rate, and the risk of incident hypertension in middle-aged men.
    Otsuka T; Kato K; Kachi Y; Ibuki C; Seino Y; Kodani E; Kawada T
    Am J Hypertens; 2014 Apr; 27(4):596-602. PubMed ID: 24008123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystatin C and blood pressure: results of 24 h ambulatory blood pressure monitoring.
    Mena C; Robles NR; de Prado JM; Gallego FG; Cidoncha A
    Eur J Intern Med; 2010 Jun; 21(3):185-90. PubMed ID: 20493420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes.
    Yang YS; Peng CH; Lin CK; Wang CP; Huang CN
    Intern Med; 2007; 46(12):801-6. PubMed ID: 17575370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
    Zhang WR; Craven TE; Malhotra R; Cheung AK; Chonchol M; Drawz P; Sarnak MJ; Parikh CR; Shlipak MG; Ix JH;
    Ann Intern Med; 2018 Nov; 169(9):610-618. PubMed ID: 30357395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.
    Van Den Noortgate NJ; Janssens WH; Delanghe JR; Afschrift MB; Lameire NH
    J Am Geriatr Soc; 2002 Jul; 50(7):1278-82. PubMed ID: 12133025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study.
    Daya N; Voskertchian A; Schneider ALC; Ballew S; McAdams DeMarco M; Coresh J; Appel LJ; Selvin E; Grams ME
    Am J Kidney Dis; 2016 Feb; 67(2):218-226. PubMed ID: 26250781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystatin C as a risk factor for outcomes in chronic kidney disease.
    Menon V; Shlipak MG; Wang X; Coresh J; Greene T; Stevens L; Kusek JW; Beck GJ; Collins AJ; Levey AS; Sarnak MJ
    Ann Intern Med; 2007 Jul; 147(1):19-27. PubMed ID: 17606957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.
    Stevens LA; Coresh J; Schmid CH; Feldman HI; Froissart M; Kusek J; Rossert J; Van Lente F; Bruce RD; Zhang YL; Greene T; Levey AS
    Am J Kidney Dis; 2008 Mar; 51(3):395-406. PubMed ID: 18295055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystatin C and aging success.
    Sarnak MJ; Katz R; Fried LF; Siscovick D; Kestenbaum B; Seliger S; Rifkin D; Tracy R; Newman AB; Shlipak MG;
    Arch Intern Med; 2008 Jan; 168(2):147-53. PubMed ID: 18227360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between serum cystatin C and hypertension among US adults without clinically recognized chronic kidney disease.
    Shankar A; Teppala S
    J Am Soc Hypertens; 2011; 5(5):378-84. PubMed ID: 21498146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystatin C and risk of heart failure in the Physicians' Health Study (PHS).
    Djoussé L; Kurth T; Gaziano JM
    Am Heart J; 2008 Jan; 155(1):82-6. PubMed ID: 18082494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.